Related Experiment Video
Updated: Jan 5, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Impaired Respiratory Function in Women With PCOS Compared With Matched Controls From a Population-Based Study
Maria Othelie Underdal1,2, Øyvind Salvesen3, Anne Hildur Henriksen4,5
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Context:
Increased prevalence of asthma has been reported from epidemiological studies in women with polycystic ovary syndrome (PCOS).
Objective:
To investigate respiratory function in women with PCOS compared with controls in a clinical setting.
Design:
An 8-year clinical follow-up study including self-reported asthma diagnoses and spirometry of women with PCOS randomized to metformin or placebo during pregnancy in the original studies (the Pilot and the PregMet-study), compared with matched controls from a population-based cohort study (The HUNT Study).
Setting:
Secondary and tertiary care centers.
Participants:
A total of 145 women with PCOS (54% of original cohort) were matched 1:3 to controls, on gender, age, and smoking-status.
Main Outcomes And Measures:
Self-reported doctor-diagnosed asthma (DDA), percentage of predicted forced expiratory volume in the first second of expiration (FEV1 % predicted), percentage of predicted forced vital capacity (FVC % predicted).
Results:
Women with PCOS reported more DDA compared with controls (19% vs 9%; P < 0.01). Spirometry indicated a combined obstructive (FEV1 % predicted, 93.7 vs 102.0; P < 0.01) and restrictive (FVC % predicted, 94.5 vs 103.7; P < 0.01) respiratory impairment in PCOS compared with controls. Metformin in pregnancy did not affect respiratory function at follow-up.
Conclusion:
Women with PCOS reported higher prevalence of DDA compared with controls matched for age and smoking status. In addition, respiratory function was decreased, with both obstructive and restrictive components. Further insight to the underlying pathogenesis of these observations is needed.
Clinical Trial Registration:
ClinicalTrials.gov: The PregMet study: NCT00159536. The Pilot study: NCT03259919.
Related Concept Videos
Oogenesis
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Disorders of the Female Reproductive System
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

